Skip to content

Clinical trials

Phase 3 Seizures trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Seizures Phase: Phase 3 Country / region: Netherlands Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20091
20101
20162
20171
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting2
Enrolling by invitation2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Longboard Pharmaceuticals2
Xenon Pharmaceuticals Inc.2
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.2
Eisai Inc.1
GlaxoSmithKline1
Jazz Pharmaceuticals1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1
Novartis Pharmaceuticals1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Zogenix, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Seizures13
Epilepsy9
Epilepsies, Myoclonic3
Epilepsies, Partial3
Brain Diseases2
Lennox Gastaut Syndrome2
Neurodevelopmental Disorders2
Tuberous Sclerosis2
Angiomyolipoma1
Astrocytoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.